The US Food and Drug Administration (FDA) has been looking into ways to test Electric Health Record (EHR)-to-Electric Data Capture (EDC) approach for clinical trials. The administration believes that this could open up new opportunities for clinical trials through design, medicines and the research cycle.
In a recent article in http://www.healthdatamanagement.com , Greg Slabodkin shares that the EHR-EDC approach can “eliminate duplication of data by capturing and transmitting electronic source data, auto-populate the electronic study forms from EHRs, reduce transcription errors and improve the quality of data, and encourage entering source data at the point of care, among other benefits.” He proposes that the EHR-EDC approach could lead to a breakthrough in science and change the way clinical trials are performed.
To find out more on FDA’s interest in EHR-EDC approach, click here to read more.